University of Nebraska Medical Center Sees Continued Success in Ultra-Long Acting HIV Medicines
June 10, 2022
June 10, 2022
OMAHA, Nebraska, June 10 (TNSjou) -- The University of Nebraska Medical Center issued the following news release:
UNMC has long been at the forefront of research and development of ultra-long acting antiviral therapy (ART) designed as vaccine mimetics for pre-exposure prophylaxis (medicine taken to prevent HIV), extended viral suppression and to facilitate in the elimination of HIV-1 infection. Now, the UNMC scientific team has extended their know-how by developing libraries of ultr . . .
UNMC has long been at the forefront of research and development of ultra-long acting antiviral therapy (ART) designed as vaccine mimetics for pre-exposure prophylaxis (medicine taken to prevent HIV), extended viral suppression and to facilitate in the elimination of HIV-1 infection. Now, the UNMC scientific team has extended their know-how by developing libraries of ultr . . .